SBX.DE

SynBiotic SE [SBX.DE] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

SBX.DE Stock Summary

Top 10 Correlated Stocks

SBX.DE

In the News

SBX.DE Financial details

Company Rating
-
Market Cap
52.34M
Income
-
Revenue
-
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
104
Optionable
No
Shortable
Yes
Earnings
23 Aug 2023
P/E
0
Forward P/E
-
PEG
-
P/S
1.94
P/B
-
P/C
-
P/FCF
-2.12
Quick Ratio
0.62
Current Ratio
1.4
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-
EPS next Y
-
EPS next Q
-
EPS this Y
40.14%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
50%
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-60%
ROE
-85%
ROC
-0.71%
Gross Margin
44%
Oper. Margin
-301%
Profit Margin
-298%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
2.86-19.5
52W High
-85.26%
52W Low
+40%
RSI
51
Rel Volume
0.25
Avg Volume
67.56K
Volume
17.11K
Perf Week
-15.66%
Perf Month
38.61%
Perf Quarter
-6.04%
Perf Half Y
-9.09%
-
-
-
-
Beta
5.19786
-
-
Volatility
0.19%, 0.68%
Prev Close
-6.67%
Price
2.8
Change
-6.67%

Something similar

Top by Market Cap
V
JPM
VFINX
BRYN.DE
NVDA
Same Sector
IONM
IBIO
RCAR
ERF.PA
MHC.L
Top Correlated Stocks
GFSTEELS.NS
TUI1.DE
ZAL.DE
CTP2.DE
UWS.DE
Similar Market Cap
WFCF
LEXI
BNDD
LQDB
FMAG

Company Profile

Healthcare Drug Manufacturers - Specialty & Generic
  • Volume Average 67.56K
  • Market Capitalization 52.34M
  • Employee 104
  • CEO Mr. Lars Muller
  • Headquarters Munich,DE
  • IPO Date 2021-01-07
  • Website https://www.synbiotic.com

SynBiotic SE engages in the development of medicines and over-the-counter wellness products based on cannabinoids. It focuses on synthetic production of cannabinoids, drug development, nutritional supplements, and cosmetic products. The company was formerly known as Ledgertech SE and changed its name to Ledgertech SE. SynBiotic SE based in Munich, Germany.